Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Pacira Pharmaceuticals Company Profile (NASDAQ:PCRX)

Consensus Ratings for Pacira Pharmaceuticals (NASDAQ:PCRX) (?)
Ratings Breakdown: 2 Sell Rating(s), 2 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $108.71 (57.98% upside)

Current Analysts' Coverage Summary for Pacira Pharmaceuticals (NASDAQ:PCRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/30/2015Canaccord GenuityLower Price TargetBuy$128.00 -> $89.00ViewTweet This Rating  Share This Rating on StockTwits
4/30/2015Brean CapitalReiterated RatingBuy$121.00 -> $92.00ViewTweet This Rating  Share This Rating on StockTwits
4/16/2015WedbushSet Price TargetBuy$127.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2015Vetr Inc.UpgradeHold -> Buy$99.05ViewTweet This Rating  Share This Rating on StockTwits
3/16/2015ZacksDowngradeOutperform -> Underperform$84.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2015BarclaysLower Price TargetOverweight$127.00 -> $115.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2015Bank of AmericaDowngradeNeutral -> Underperform$112.00 -> $110.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2015TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/25/2015Piper JaffraySet Price TargetBuy$136.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Goldman SachsBoost Price Target$126.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2014Jefferies GroupReiterated RatingBuy$86.00 -> $109.00ViewTweet This Rating  Share This Rating on StockTwits
6/17/2014JMP SecuritiesInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
3/18/2014National Alliance SecuritiesInitiated CoverageBuy$109.41ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 5/3/2013 forward)